Effect of rizatriptan and other triptans on the nausea symptom of migraine: A post hoc analysis

Headache

Volumn 41, Issue 8, 2001, Pages 754-763

  Lipton, Richard B ^a,b,g   Pascual, Julio ^c   Goadsby, Peter J ^d   Massiou, Helene ^e   McCarroll, Kathleen A ^f   Vandormael, Kristel ^f   Jiang, Kaihong ^f   Lines, Christopher R ^f  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Innovative Medical Research   (United States)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e HÔPITAL LARIBOISIÈRE   (France)

^f MERCK RESEARCH LABORATORIES   (United States)

^g Innovative Medical Research Inc   (United States)

Author keywords

5 HT1B 1D receptor agonists; Baseline; Emergent; Migraine; Naratriptan; Nausea; Rizatriptan; Sumatriptan; Zolmitriptan

Indexed keywords

NARATRIPTAN; RIZATRIPTAN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN; ZOLMITRIPTAN;

ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; HUMAN; INCIDENCE; MIGRAINE; NAUSEA; PRIORITY JOURNAL;

EID: 0034797195     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2001.01139.x     Document Type: Article

References (7)

1. Llewelyn JG, Findley LJ, Gross ML. Migraine symptoms: which cause the most distress? In: Olesen J, Tfelt-Hansen P, eds. Headache Treatment: Trial Methodology and New Drugs. Philadelphia, Pa: Lippinicott-Raven; 1997:153-156.
2. Solomon GD, Cady RK, Klapper JA, Earl NL, Saper JR, Ramadan NM, on behalf of the 042 Clinical Trial Study Group. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. Neurology. 1997;49:1219-1225.
3. Mathew NT, Asgharnejad M, Peykamian M, Laurenza A, on behalf of the Naratriptan S2WA3003 Study Group. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. Neurology. 1997;49:1485-1490.
4. Goadsby PJ, Ferrari MD, Olesen J, et al for the Eletriptan Steering Committee. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Neurology. 2000;54:156-163.
5. Lipton RB. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles. Headache. 1997;37(suppl 1):S33-S41.
6. Tfelt-Hansen P, Teall J, Rodriguez F, et al on behalf of the Rizatriptan 030 Study Group. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Headache. 1998;38:748-755.
7. Goldstein J, Ryan R, Jiang K, et al. Crossover comparison of rizatriptan 5 mg and 10 mg vs sumatriptan 25 mg and 50 mg in migraine. Headache. 1998;38:737-747.